Literature DB >> 16130093

Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy.

Betti Giusti1, Laura Lucarini, Valentina Pietroni, Simona Lucioli, Brunella Bandinelli, Patrizia Sabatelli, Stefano Squarzoni, Stefania Petrini, Corine Gartioux, Beril Talim, Filip Roelens, Luciano Merlini, Haluk Topaloglu, Enrico Bertini, Pascale Guicheney, Guglielmina Pepe.   

Abstract

In this study, we characterized five Ullrich scleroatonic muscular dystrophy patients (two Italians, one Belgian, and two Turks) with a clinical phenotype showing different degrees of severity, all carrying mutations localized in COL6A1. We sequenced the three entire COL6 complementary DNA. Three of five patients have recessive mutations: two patients (P1and P3) have homozygous single-nucleotide deletions, one in exon 9 and one in exon 22; one patient (P2) has a homozygous single-nucleotide substitution leading to a premature termination codon in exon 31. The nonsense mutation of P2 also causes a partial skipping of exon 31 with the formation of a premature termination codon in exon 32 in 15% of the total COL6A1 messenger RNA. The remaining two patients carry a heterozygous glycine substitution in exons 9 and 10 inside the triple-helix region; both are dominant mutations because the missense mutations are absent in the DNA of their respective parents. As for the three homozygous recessive mutations, the apparently healthy consanguineous parents all carry a heterozygous mutated allele. Here, for the first time, we report a genotype-phenotype correlation demonstrating that heterozygous glycine substitutions in the triple-helix domain of COL6A1 are dominant and responsible for a milder Ullrich scleroatonic muscular dystrophy phenotype, and that recessive mutations in COL6A1 correlate with more severe clinical and biochemical Ullrich scleroatonic muscular dystrophy phenotypes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16130093     DOI: 10.1002/ana.20586

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

1.  Collagen VI microfibril formation is abolished by an {alpha}2(VI) von Willebrand factor type A domain mutation in a patient with Ullrich congenital muscular dystrophy.

Authors:  Leona D Tooley; Laura K Zamurs; Nicola Beecher; Naomi L Baker; Rachel A Peat; Naomi E Adams; John F Bateman; Kathryn N North; Clair Baldock; Shireen R Lamandé
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

2.  Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant.

Authors:  Rui-Zhu Zhang; Yaqun Zou; Te-Cheng Pan; Dessislava Markova; Andrzej Fertala; Ying Hu; Stefano Squarzoni; Umbertina Conti Reed; Suely K N Marie; Carsten G Bönnemann; Mon-Li Chu
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

Review 3.  The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.

Authors:  Carsten G Bönnemann
Journal:  Handb Clin Neurol       Date:  2011

4.  A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16.

Authors:  Te-Cheng Pan; Rui-Zhu Zhang; Machiko Arita; Sasha Bogdanovich; Sheila M Adams; Sudheer Kumar Gara; Raimund Wagener; Tejvior S Khurana; David E Birk; Mon-Li Chu
Journal:  J Biol Chem       Date:  2014-02-22       Impact factor: 5.157

5.  Complexities in Genotype-Phenotype Correlation and Genetic Counseling in Collagen VI - Related Myopathy.

Authors:  Malavika Hebbar; Tanya Chandra; Anju Shukla; Rajagopal Kadavigere; Katta M Girisha
Journal:  Indian J Pediatr       Date:  2016-12-21       Impact factor: 1.967

Review 6.  The triple helix of collagens - an ancient protein structure that enabled animal multicellularity and tissue evolution.

Authors:  Aaron L Fidler; Sergei P Boudko; Antonis Rokas; Billy G Hudson
Journal:  J Cell Sci       Date:  2018-04-09       Impact factor: 5.285

7.  Bethlem myopathy: a series of 16 patients and description of seven new associated mutations.

Authors:  Luísa Panadés-de Oliveira; Claudia Rodríguez-López; Diana Cantero Montenegro; María Del Mar Marcos Toledano; Ana Fernández-Marmiesse; Jesús Esteban Pérez; Aurelio Hernández Lain; Cristina Domínguez-González
Journal:  J Neurol       Date:  2019-01-31       Impact factor: 4.849

8.  Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity.

Authors:  Rishika A Pace; Rachel A Peat; Naomi L Baker; Laura Zamurs; Matthias Mörgelin; Melita Irving; Naomi E Adams; John F Bateman; David Mowat; Nicholas J C Smith; Phillipa J Lamont; Steven A Moore; Katherine D Mathews; Kathryn N North; Shireen R Lamandé
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

9.  Zebrafish models of collagen VI-related myopathies.

Authors:  W R Telfer; A S Busta; C G Bonnemann; E L Feldman; J J Dowling
Journal:  Hum Mol Genet       Date:  2010-03-25       Impact factor: 6.150

10.  Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies.

Authors:  Matteo Bovolenta; Marcella Neri; Elena Martoni; Anna Urciuolo; Patrizia Sabatelli; Marina Fabris; Paolo Grumati; Eugenio Mercuri; Enrico Bertini; Luciano Merlini; Paolo Bonaldo; Alessandra Ferlini; Francesca Gualandi
Journal:  BMC Med Genet       Date:  2010-03-19       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.